New research (see it here) has shown that the anti-oestrogens raloxifene and gonadorelin block the formation of colorectal tumours in female mice genetically pre-disposed (so called ApcMin/+ mice) to develop colorectal cancer. Anti-oestrogens inhibited tumour formation...
